Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
You are here
Home
News by month %2 2019
News by month March 2019
PTCommunity News March 2019
Methotrexate Gets Orphan Drug Status for Treatment of Ectopic Pregnancy
New Testosterone Treatment for Certain Forms of Hypogonadism
New Drug Approved for Relapsing Forms of Multiple Sclerosis in Adults
Some Implantable Cardiac Devices Have Cybersecurity Flaw
Treprostinil Injection for Treatment of Pulmonary Arterial Hypertension Launched in U.S.
Researchers Find 413 Genes Associated With Schizophrenia
New Trials of ECT-001 Cleared for Possible Treatment of Leukemia
New Device Approved for Chronic Heart Failure
Sunosi™ Approved for Excessive Daytime Sleepiness From Narcolepsy or Obstructive Sleep Apnea
FDA Approves Zulresso™ Injection for Postpartum Depression
New Treatment for Acute Myeloid Leukemia Has Startling Results
Researchers Identify Possible New Therapy for Pancreatic Cancer
FDA Approves Tecentriq for Adults With Extensive-Stage Small Cell Lung Cancer
Saracatinib Receives Orphan Drug Designation for Idiopathic Pulmonary Fibrosis
New Class of Drugs Could Halt Ovarian Cancer Cell Growth
Stroke Survivors Regain Movement With Video-Game Device
Rate of Dementia Deaths in U.S. Has More Than Doubled Since 2000, CDC Says
New Generic Valsartan Approved
Johnson & Johnson Hit With $29 Million Verdict in Talc Cancer Case
New Drug May Prevent Recurrence, Improve Survival in Ovarian Cancer
FDA Issues Alert About Surgical Staplers and Implantable Surgical Staples
Guardian Pharmacy Services Ordered to Halt Production of Compounded Drugs
Experimental Drug Limits Muscle Damage from Heart Attack
Tecentriq Approved As First Immunotherapy for Breast Cancer
New Compound Gets Orphan Drug Status for Huntington’s Disease
New Therapy for Charcot-Marie-Tooth Disease Gets Orphan Drug Designation
After 12 Years, HIV Reportedly Cured in a Second Patient
FDA Urges Caution With Robotically Assisted Surgical Devices
